ESSENTIAL PHOSPHOLIPIDS IN THE COMPLEX THERAPY OF NON-ALCOHOLIC FATTY LIVER DISEASE.

Abstract

Annotation.Non-alcoholic fatty liver disease (NAFLD) attracts the attention of a wide range of specialists as a multifactorial disease. According to the results of numerous studies, it has been found that the most common risk factors for NAFLD are hypertension, dyslipidemia, hypercholesterolemia, abdominal obesity, type 2 diabetes mellitus. Therefore, an integrated approach to the treatment of this disease remains relevant at the present time. Along with the use of the main drugs used to treat NAFLD, hepatoprotectors - essential phospholipids (EFL) are actively used.